Abstract
The influenza virus hemagglutinin (HA) mediates membrane fusion after viral entry by endocytosis. The fusion process requires drastic low pH-induced HA refolding and is prevented by arbidol and tert-butylhydroquinone (TBHQ). We here report a class of superior inhibitors with indole-substituted spirothiazolidinone structure. The most active analogue 5f has an EC50 value against influenza A/H3N2 virus of 1 nM and selectivity index of almost 2000. Resistance data and in silico modeling indicate that 5f combines optimized fitting in the TBHQ/arbidol HA binding pocket with a capability for endosomal accumulation. Both criteria appear relevant to achieve superior inhibitors of HA-mediated fusion.
Keywords:
Antiviral; Fusion; Hemagglutinin; In silico; Indole; Influenza virus; Inhibitor; Spirothiazolidinone.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antiviral Agents / chemical synthesis
-
Antiviral Agents / chemistry
-
Antiviral Agents / pharmacology*
-
Dogs
-
Dose-Response Relationship, Drug
-
Hemagglutinin Glycoproteins, Influenza Virus / drug effects*
-
Humans
-
Hydrogen-Ion Concentration
-
Indoles / chemistry
-
Indoles / pharmacology*
-
Influenza A Virus, H3N2 Subtype / drug effects*
-
Influenza, Human / drug therapy*
-
Madin Darby Canine Kidney Cells / drug effects
-
Madin Darby Canine Kidney Cells / virology
-
Microbial Sensitivity Tests
-
Molecular Docking Simulation
-
Molecular Structure
-
Protein Refolding / drug effects
-
Spiro Compounds / chemistry
-
Spiro Compounds / pharmacology*
-
Structure-Activity Relationship
-
Thiazolidines / chemistry
-
Thiazolidines / pharmacology*
Substances
-
Antiviral Agents
-
Hemagglutinin Glycoproteins, Influenza Virus
-
Indoles
-
Spiro Compounds
-
Thiazolidines
-
indole